KATHRYN OYER: Open Payments
NPI 1891413290 · SAYRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 28 payments from 14 companies in 2025. Trend: 2023 $82 · 2024 $894 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $79 |
| BridgeBio Pharma, Inc. | 4 | $78 |
| Actelion Pharmaceuticals US, Inc. | 2 | $48 |
| Amgen Inc. | 2 | $35 |
| ABIOMED | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Chiesi USA, Inc. | 1 | $26 |
| AtriCure, Inc. | 1 | $18 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
Products named: Wegovy, JARDIANCE, Attruby, OPSYNVI, REPATHA, LEQVIO, CLEVIPREX, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX.
Industry payments across PA — which companies pay providers there.
